DK3448416T3 - Semaglutid ved kardiovaskulære tilstande - Google Patents

Semaglutid ved kardiovaskulære tilstande Download PDF

Info

Publication number
DK3448416T3
DK3448416T3 DK17721109.1T DK17721109T DK3448416T3 DK 3448416 T3 DK3448416 T3 DK 3448416T3 DK 17721109 T DK17721109 T DK 17721109T DK 3448416 T3 DK3448416 T3 DK 3448416T3
Authority
DK
Denmark
Prior art keywords
semaglutid
cardiovascular conditions
cardiovascular
conditions
Prior art date
Application number
DK17721109.1T
Other languages
Danish (da)
English (en)
Inventor
Oluf Kristian Højbjerg Hansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58668875&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3448416(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of DK3448416T3 publication Critical patent/DK3448416T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
DK17721109.1T 2016-04-28 2017-04-28 Semaglutid ved kardiovaskulære tilstande DK3448416T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16167458 2016-04-28
EP16188262 2016-09-12
PCT/EP2017/060160 WO2017186896A1 (en) 2016-04-28 2017-04-28 Semaglutide in cardiovascular conditions

Publications (1)

Publication Number Publication Date
DK3448416T3 true DK3448416T3 (da) 2022-10-03

Family

ID=58668875

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17721109.1T DK3448416T3 (da) 2016-04-28 2017-04-28 Semaglutid ved kardiovaskulære tilstande

Country Status (24)

Country Link
US (3) US20190134162A1 (OSRAM)
EP (1) EP3448416B1 (OSRAM)
JP (1) JP7221694B2 (OSRAM)
KR (3) KR102778218B1 (OSRAM)
CN (1) CN109069589B (OSRAM)
AU (2) AU2017256774B2 (OSRAM)
BR (1) BR112018072020A2 (OSRAM)
CA (1) CA3022535A1 (OSRAM)
CL (1) CL2018003045A1 (OSRAM)
DK (1) DK3448416T3 (OSRAM)
ES (1) ES2928007T3 (OSRAM)
HR (1) HRP20221150T1 (OSRAM)
HU (1) HUE060040T2 (OSRAM)
IL (1) IL262390B1 (OSRAM)
MA (1) MA44762A (OSRAM)
MX (1) MX2018012700A (OSRAM)
MY (1) MY202967A (OSRAM)
PH (1) PH12018502274B1 (OSRAM)
PL (1) PL3448416T3 (OSRAM)
RS (1) RS63630B1 (OSRAM)
RU (1) RU2768283C2 (OSRAM)
SI (1) SI3448416T1 (OSRAM)
WO (1) WO2017186896A1 (OSRAM)
ZA (2) ZA202507395B (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102778218B1 (ko) * 2016-04-28 2025-03-10 노보 노르디스크 에이/에스 심혈관 병태에서의 세마글루타이드
JP6633777B2 (ja) 2017-08-24 2020-01-22 ノヴォ ノルディスク アー／エス Ｇｌｐ−１組成物及びその使用
MY206306A (en) * 2018-10-26 2024-12-07 Novo Nordisk As Stable semaglutide compositions and uses thereof
WO2020127950A1 (en) * 2018-12-21 2020-06-25 Novo Nordisk A/S Process of spray drying of glp-1 peptide
AU2021208601B2 (en) * 2020-02-18 2025-06-05 Novo Nordisk A/S Glp-1 compositions and uses thereof
CN114699510B (zh) * 2021-12-29 2024-07-16 浙江湃肽生物有限公司 一种司美格鲁肽微针阵列及其制备方法
AU2023285400A1 (en) * 2022-06-08 2024-12-05 Zydus Lifesciences Limited Reusable multi-dose, variable dose, single pen injector for type 2 diabetes and weight management
CN117462654A (zh) * 2023-09-28 2024-01-30 武汉大学人民医院（湖北省人民医院） 司美格鲁肽在制备预防或治疗心肌重构的药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005535569A (ja) * 2002-04-04 2005-11-24 ノボ・ノルデイスク・エー／エス Ｇｌｐ−１アゴニスト及び心臓血管合併症
TWI372629B (en) * 2005-03-18 2012-09-21 Novo Nordisk As Acylated glp-1 compounds
KR101819609B1 (ko) * 2010-05-05 2018-01-17 베링거 인겔하임 인터내셔날 게엠베하 체중 감소 치료에 후속하는 dpp-4 억제제에 의한 순차적 병용 요법
PL3326620T3 (pl) * 2010-12-16 2020-08-24 Novo Nordisk A/S Kompozycje stałe zawierające agonistę glp-1 i sól kwasu n-(8-(2- hydroksybenzoilo)amino)kaprylowego
US20130035281A1 (en) * 2011-02-09 2013-02-07 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
CN104039822A (zh) * 2011-09-06 2014-09-10 诺沃—诺迪斯克有限公司 Glp-1衍生物
KR20160075819A (ko) * 2013-11-15 2016-06-29 노보 노르디스크 에이/에스 선택적 pyy 화합물 및 그것의 사용
KR102778218B1 (ko) 2016-04-28 2025-03-10 노보 노르디스크 에이/에스 심혈관 병태에서의 세마글루타이드

Also Published As

Publication number Publication date
US20250262281A1 (en) 2025-08-21
MY202967A (en) 2024-05-31
JP7221694B2 (ja) 2023-02-14
RU2768283C2 (ru) 2022-03-23
PL3448416T3 (pl) 2022-11-07
WO2017186896A1 (en) 2017-11-02
KR20180135012A (ko) 2018-12-19
ZA202507394B (en) 2025-09-25
MA44762A (fr) 2019-03-06
RU2018140900A (ru) 2020-05-28
AU2017256774B2 (en) 2024-07-11
ES2928007T3 (es) 2022-11-14
RU2018140900A3 (OSRAM) 2020-09-28
CN109069589B (zh) 2022-09-06
HRP20221150T1 (hr) 2022-11-25
EP3448416A1 (en) 2019-03-06
JP2019514925A (ja) 2019-06-06
IL262390A (en) 2018-12-31
AU2017256774A1 (en) 2018-11-01
HUE060040T2 (hu) 2023-01-28
IL262390B1 (en) 2023-05-01
CN109069589A (zh) 2018-12-21
US20190134162A1 (en) 2019-05-09
EP3448416B1 (en) 2022-08-10
ZA202507395B (en) 2025-09-25
KR102778218B1 (ko) 2025-03-10
MX2018012700A (es) 2019-01-30
CA3022535A1 (en) 2017-11-02
PH12018502274B1 (en) 2024-02-28
US20250288649A1 (en) 2025-09-18
AU2024227113A1 (en) 2024-10-31
PH12018502274A1 (en) 2019-09-09
RS63630B1 (sr) 2022-10-31
CL2018003045A1 (es) 2018-12-14
KR20220147712A (ko) 2022-11-03
KR20250038818A (ko) 2025-03-19
SI3448416T1 (sl) 2022-10-28
BR112018072020A2 (pt) 2019-02-12

Similar Documents

Publication Publication Date Title
EP3374114A4 (en) WORKBENCH
DK3283625T3 (da) Nukleasemedieret genomeditering
DK3331869T3 (da) Muscarinagonister
DK3331528T3 (da) Muskarinagonister
DK3277719T3 (da) Polypeptider
DK3305788T3 (da) Janus-kinase-hæmmer
DK3331529T3 (da) Muskarinagonister
DK3448416T3 (da) Semaglutid ved kardiovaskulære tilstande
DK3310450T3 (da) Olie-vand-separator
EP3341259A4 (en) WHEELBARROW
DK3242685T3 (da) Cxcr4-bindende molekyler
DK3270930T3 (da) Præeklampsi
DK3292136T3 (da) Penicillin-g-acylaser
DK3551355T3 (da) Immobiliseret indsats
DE112015006486A5 (de) Inkubationsrinne
DE112016001806A5 (de) Bausatz
DK3253755T3 (da) Hidtil ukendte cyclopropabenzofuranyl-pyridopyrazindioner
DK3274482T3 (da) Stenborsknop
DE102015206660A8 (de) Plattenaufteilanlage
DK3318308T3 (da) Badmintonketsjer
DK3423082T3 (da) Liraglutid ved kardiovaskulære tilstande
DE112015005906A5 (de) Gurtschlossbringer
DE112016005599A5 (de) Strahlungsgrill
UY4439S (es) Trofeo
DE102015000551A8 (de) Rotationszerstäuberturbine